TABLE 1.
Treatmentsa |
Peptideb | Observed massc | Calculated massd | Mass difference/commente | |
---|---|---|---|---|---|
1st digest | 2nd digest | ||||
Da | Da | ||||
T1 | Ile1–Arg152 | 28,000† | 16,891 | 11109 (P and O-glycans) | |
Asp-N | Asp145–Arg152 | 908.48 | 908.48 | Normal isotope pattern | |
T2 | Ser153–Arg228 | 9043.05†/8961.76† | 8642.20 | 400.85 (5P)/319.56 (4P) | |
T3 | Ser153–Asn298 | 17,888.52† | 16,843.08 | 1045.44 (13P) | |
T4 | Leu229–Asn298 | 8864.33† | 8219.90 | 644.43 (8P) | |
P1 | Ile1–Arg152 | 28,200† | 16,891 | 11,309 (P and O-glycans) | |
Ile1–Lys154 | 17,106 | 11,094 (P and O-glycans) | |||
Asp-N | Asp145–Arg152 | 908.49 | 908.48 | Normal isotope pattern | |
Asp-N | Asp145–Lys154 | 1123.64 | 1123.60 | Normal isotope pattern | |
P2 | Ser153–Lys187 | 4325.60 | 4085.94 | 239.66 (3P) | |
P3 | Ser155–Lys187 | 4110.60/4030.59 | 3870.82 | 239.78 (3P)/159.77 (2P) | |
P4 | Phe158–Lys187 | 3767.47/3687.40 | 3527.59 | 239.88 (3P)/159.81 (2P) | |
P5 | Arg160–Lys187 | 3464.16/3384.20 | 3224.43 | 239.73 (3P)/159.77 (2P) | |
P6 | Ala188–Lys225 | 4519.15†/4438.67 | 4198.91 | 317.78 (4P)/239.76 (3P) | |
P7 | Ala188–Lys231 | 5294.22†/5214.29† | 4977.28 | 316.94 (4P)/237.01 (3P) | |
P8 | Arg232–Lys283 | 6620.45† | 6142.62 | 477.83 (6P) | |
P9 | Phe284–Asn298 | 1930.56 | 1690.80 | 239.76 (3P) | |
CD1 | Ile1–Thr26 | 3078.35 | 2838.41 | 239.94 (3P) | |
CD2 | Trp27–Leu38 | 1439.60 | 1439.72 | ||
CD3 | Trp27–Phe53 | 3202.35 | 3042.44 | 159.91 (2P) | |
CD4 | Leu39–Leu151 | 22,200† | 12,492 | 9708 (P and O-glycans) | |
Lys54–Leu151 | 10,888 | 11,312 (P and O-glycans) | |||
Asp-N | Asp145–Leu151 | 752.29 | 752.38 | Normal isotope pattern | |
CD5 | Arg152–Leu195 | 5289.17 | 5049.49 | 239.68 (3P) | |
CD6 | Asn196–Leu229 | 4115.70/4037.73† | 3875.74 | 239.96 (3P)/159.75 (2P) | |
CD7 | Ser251–Leu269 | 2594.90 | 2339.05 | 255.85 (3P, Mox) | |
CD8 | Val270–Asn298 | 3643.30 | 3323.68 | 319.62 (4P) |
a Fractions were from the digestion of OPN with thrombin (T), plasmin (P), or cathepsin D (CD). In some cases, the fragments were further digested with endoproteinase Asp-N in buffer containing 50% H218O.
b Peptides were identified by N-terminal sequence and MALDI-TOF-MS analyses.
c Observed molecular masses (MH+) were determined by MALDI-TOF-MS. Unless mentioned otherwise, masses are monoisotopic. † means the molecular masses were determined in linear mode.
d Theoretical calculated masses are shown.
e Differences between observed and calculated masses are shown. The type of modification corresponding to the mass difference is given in parentheses as follows: phosphorylation (P) and oxidation of methionine (Mox). The C terminus of fragments secondarily digested with Asp-N in 50% H218O was identified by observation of peptides with a normal isotopic pattern.